Center For Drug & Health Studies

Focus Insite LLC is a leading qualitative market research recruitment company based in West Chester, PA. They specialize in recruiting highly qualified and dependable participants for consumer, B2B, medical, and technical studies. With a commitment to clear communication, personalized experiences, and flexible options, Focus Insite ensures a positive experience for both project recruiters and study participants. As a single point of contact for domestic and international recruitment, moderation, transcription, and translation services, Focus Insite takes the hassle out of finding the right participants for research activities. Their core values of building relationships, maintaining a positive attitude, practicing transparency, and taking ownership of their work drive their success in serving global brands across various industries.Generated from the website

Neuraptive Therapeutics, Inc. is a Philadelphia-based company dedicated to developing innovative therapeutics and medical products for physicians and patients affected by peripheral nerve injuries. With a focus on improving the speed and outcomes of peripheral nerve injuries, Neuraptive has in-licensed technology from the University of Texas at Austin, including a novel fusion system for repairing severed peripheral nerves, a specialized drug delivery device for topical administration, and nerve-specific microsurgical instruments to address current limitations in the field of nerve repair. With their revolutionary surgical treatment kit, NTX-001, Neuraptive aims to revolutionize nerve repair by leveraging the 505(b)(2) development pathway and utilizing previously approved pharmaceutical ingredients presented in sterile solutions. With a significant market opportunity in the US and globally, Neuraptive's products have the potential to make a substantial impact on the lives of millions of patients undergoing nerve repair procedures.Generated from the website

Zynerba Pharmaceuticals, Inc. is an orphan-focused, neuropsychiatric biopharmaceutical company based in Devon, PA. They are dedicated to developing innovative transdermal cannabinoid treatments for patients with rare neurological diseases, with a particular focus on improving the lives of those battling certain rare conditions. Recently acquired by Harmony Biosciences, Zynerba Pharmaceuticals is at the forefront of pioneering cannabinoid therapies for neuropsychiatric conditions. Their ongoing RECONNECT clinical trial is open for recruitment, offering patients, families, and healthcare providers an opportunity to learn more about Fragile X syndrome and access potential treatments. With a mission to advance science and improve connections, Zynerba Pharmaceuticals is committed to addressing unmet medical needs in the field of rare disorders.Generated from the website